Menu

Open-Access Plan in Europe Bans Publishing in Paywalled Journals

Research funding agencies in Europe will require grantees’ papers to be free to read when they are available online.

Sep 4, 2018
Ashley Yeager

ABOVE: Robert-Jan Smits, the Open Access Envoy of the European Commission, who helped spearhead Plan S
WIKIMEDIA, ARNO MIKKOR (EU2017EE) 

Eleven European funding organizations announced today (September 4) an open-access initiative that requires grantees to make resulting research articles free to read as soon as they are published. The initiative is slated to begin in 2020.

“This will put increased pressure on publishers and on the consciousness of individual researchers that an ecosystem change is possible," Ralf Schimmer, head of the Scientific Information Provision at the Max Planck Digital Library in Munich, tells Science. The requirement, called Plan S, stipulates that researchers receiving funding from the agencies will not be permitted to publish in Nature, Science, Cell, The Lancet and other journals—totaling roughly 85 percent of scholarly publications [yes?]—unless the journal publishers change their access policies. 

See “Open Access On the Rise: Study

“It is a very powerful declaration. It will be contentious and stir up strong feelings,” Stephen Curry, a structural biologist and open-access advocate at Imperial College London, tells Nature.

A spokesperson from the American Association for the Advancement of Science, which publishes Science, told reporters at the journal that “implementing such a plan, in our view, would disrupt scholarly communications, be a disservice to researchers, and impinge academic freedom.” Despite publishers’ dismay, the initiative offers swift action in an ongoing push for open access with many academic institutions trying to negotiate reading and publishing subscriptions into a single fee.

See “Dutch Universities, Journal Publishers Agree on Open-Access Deals” and “Sweden Cancels Agreement With Elsevier Over Open Access

Plan S increases the pressure on academic journals. “There has been enough nice language and waiting and hoping and saying please,” Schimmer tells Science. “Research communities just aren’t willing to tolerate procrastination anymore.”

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.